Literature DB >> 21726817

Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding.

Simon C Biddie1, Sam John, Pete J Sabo, Robert E Thurman, Thomas A Johnson, R Louis Schiltz, Tina B Miranda, Myong-Hee Sung, Saskia Trump, Stafford L Lightman, Charles Vinson, John A Stamatoyannopoulos, Gordon L Hager.   

Abstract

Ligand-dependent transcription by the nuclear receptor glucocorticoid receptor (GR) is mediated by interactions with coregulators. The role of these interactions in determining selective binding of GR to regulatory elements remains unclear. Recent findings indicate that a large fraction of genomic GR binding coincides with chromatin that is accessible prior to hormone treatment, suggesting that receptor binding is dictated by proteins that maintain chromatin in an open state. Combining DNaseI accessibility and chromatin immunoprecipitation with high-throughput sequencing, we identify the activator protein 1 (AP1) as a major partner for productive GR-chromatin interactions. AP1 is critical for GR-regulated transcription and recruitment to co-occupied regulatory elements, illustrating an extensive AP1-GR interaction network. Importantly, the maintenance of baseline chromatin accessibility facilitates GR recruitment and is dependent on AP1 binding. We propose a model in which the basal occupancy of transcription factors acts to prime chromatin and direct inducible transcription factors to select regions in the genome.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726817      PMCID: PMC3138120          DOI: 10.1016/j.molcel.2011.06.016

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

1.  A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis.

Authors:  M Olive; D Krylov; D R Echlin; K Gardner; E Taparowsky; C Vinson
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays.

Authors:  Peter J Sabo; Michael S Kuehn; Robert Thurman; Brett E Johnson; Ericka M Johnson; Hua Cao; Man Yu; Elizabeth Rosenzweig; Jeff Goldy; Andrew Haydock; Molly Weaver; Anthony Shafer; Kristin Lee; Fidencio Neri; Richard Humbert; Michael A Singer; Todd A Richmond; Michael O Dorschner; Michael McArthur; Michael Hawrylycz; Roland D Green; Patrick A Navas; William S Noble; John A Stamatoyannopoulos
Journal:  Nat Methods       Date:  2006-07       Impact factor: 28.547

3.  Retinoic acid is a negative regulator of AP-1-responsive genes.

Authors:  R Schüle; P Rangarajan; N Yang; S Kliewer; L J Ransone; J Bolado; I M Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

4.  Mechanism of DNase I hypersensitive site formation within the human globin locus control region.

Authors:  C H Lowrey; D M Bodine; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

5.  Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Authors:  Jason S Carroll; X Shirley Liu; Alexander S Brodsky; Wei Li; Clifford A Meyer; Anna J Szary; Jerome Eeckhoute; Wenlin Shao; Eli V Hestermann; Timothy R Geistlinger; Edward A Fox; Pamela A Silver; Myles Brown
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

6.  Protein-protein interactions in gene regulation: the cAMP-CRP complex sets the specificity of a second DNA-binding protein, the CytR repressor.

Authors:  L Søgaard-Andersen; P Valentin-Hansen
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

7.  Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.

Authors:  F Saatcioglu; G Lopez; B L West; E Zandi; W Feng; H Lu; A Esmaili; J W Apriletti; P J Kushner; J D Baxter; M Karin
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

8.  Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.

Authors:  R Schüle; P Rangarajan; S Kliewer; L J Ransone; J Bolado; N Yang; I M Verma; R M Evans
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

9.  The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression.

Authors:  Hans F Luecke; Keith R Yamamoto
Journal:  Genes Dev       Date:  2005-05-01       Impact factor: 11.361

10.  Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor.

Authors:  Alex Yick-Lun So; Christina Chaivorapol; Eric C Bolton; Hao Li; Keith R Yamamoto
Journal:  PLoS Genet       Date:  2007-06       Impact factor: 5.917

View more
  240 in total

1.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  More to Hi-C than meets the eye.

Authors:  Myong-Hee Sung; Gordon L Hager
Journal:  Nat Genet       Date:  2011-10-27       Impact factor: 38.330

3.  Cancer: Reprogramming clinical outcome.

Authors:  Geneviève Deblois; Vincent Giguère
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

4.  Modulation of chromatin access during adipocyte differentiation.

Authors:  Susanne Mandrup; Gordon L Hager
Journal:  Nucleus       Date:  2012 Jan-Feb       Impact factor: 4.197

Review 5.  Enhancers: emerging roles in cell fate specification.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  EMBO Rep       Date:  2012-04-10       Impact factor: 8.807

Review 6.  Glucocorticoid-Induced Osteoporosis.

Authors:  Baruch Frenkel; Wendy White; Jan Tuckermann
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

7.  eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci.

Authors:  Kambiz Mousavi; Hossein Zare; Stefania Dell'orso; Lars Grontved; Gustavo Gutierrez-Cruz; Assia Derfoul; Gordon L Hager; Vittorio Sartorelli
Journal:  Mol Cell       Date:  2013-08-29       Impact factor: 17.970

8.  A conserved protein motif is required for full modulatory activity of negative elongation factor subunits NELF-A and NELF-B in modifying glucocorticoid receptor-regulated gene induction properties.

Authors:  Min Luo; Xinping Lu; Rong Zhu; Zhenhuan Zhang; Carson C Chow; Rong Li; S Stoney Simons
Journal:  J Biol Chem       Date:  2013-10-06       Impact factor: 5.157

Review 9.  Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor.

Authors:  Tina B Miranda; Stephanie A Morris; Gordon L Hager
Journal:  Mol Cell Endocrinol       Date:  2013-03-14       Impact factor: 4.102

10.  Direct GR Binding Sites Potentiate Clusters of TF Binding across the Human Genome.

Authors:  Christopher M Vockley; Anthony M D'Ippolito; Ian C McDowell; William H Majoros; Alexias Safi; Lingyun Song; Gregory E Crawford; Timothy E Reddy
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.